No peptide has been shown to slow human ageing. What the research offers is more specific and, in its way, more interesting: individual molecules that act on individual biological processes linked to ageing, studied mostly in cells and animals. The clearest way to understand them is to sort them by which of those processes they target.
This guide does that, using the scientific framework of the “hallmarks of ageing”, and is honest about how far each peptide has actually been tested.
The short answer
- “Anti-aging peptides” is a loose label for peptides studied against specific processes linked to ageing, such as telomere shortening, mitochondrial decline, cellular senescence and chronic inflammation.
- Epitalon is studied in telomere research, SS-31, MOTS-c and humanin in mitochondrial research, FOXO4-DRI in senescence, and GHK-Cu in tissue repair.
- Only two in this guide have reached approval anywhere, each for one specific disease: SS-31 (elamipretide) for Barth syndrome in the US, and thymosin alpha-1 abroad.
- None is approved to treat or slow ageing, and most of the evidence comes from cell and animal studies.
- Pure Peptides Canada supplies them as laboratory research reagents, not for human use.
The hallmarks of ageing
In 2013, Carlos López-Otín and colleagues published a framework in Cell that sorted the biology of ageing into nine “hallmarks”, processes that change with age, speed ageing when aggravated in experiments, and slow it when improved. A 2023 update expanded the list to twelve: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis.
The framework is useful here because it turns a vague promise, “anti-aging”, into a testable question: which hallmark does this peptide act on, and in what?
Peptides mapped to hallmarks
| Hallmark | Peptide | What was studied | Full guide |
|---|---|---|---|
| Telomere attrition | Epitalon | hTERT expression and telomere length in cultured human cells (2003, replicated 2025) | Epitalon |
| Mitochondrial dysfunction | SS-31 | Binds cardiolipin in the inner mitochondrial membrane | Mitochondrial peptides |
| Mitochondrial dysfunction, nutrient sensing | MOTS-c | AMPK activation and metabolism in mice; rises with exercise in people | Mitochondrial peptides |
| Cellular senescence | FOXO4-DRI | Apoptosis of senescent cells; fur, fitness and kidney function in aged mice | FOXO4-DRI |
| Chronic inflammation | KPV, thymosin alpha-1 | Colitis models (KPV); immune modulation and clinical trials (thymosin alpha-1) | KPV, TA1 |
| Epigenetic alterations (proposed) | Pinealon, Epitalon | A gene-regulation hypothesis from the St. Petersburg bioregulator group | Pinealon |
| Tissue repair (not a formal hallmark) | GHK-Cu | Collagen synthesis, wound models and gene-expression data | GHK-Cu |
Two reminders about this table. A peptide appearing next to a hallmark means researchers have studied it there, not that it reverses that hallmark. And NAD+, often grouped with these peptides, is not a peptide at all: it is a coenzyme that sirtuin enzymes need, and its levels fall with age in several tissues.
How far each has been tested
Anti-aging and cellular research peptides, each with a batch COA.
Browse the categoryHow to read anti-aging claims
The longevity field moves fast, and marketing moves faster. Three questions cut through most claims:
- What was measured? A rise in a gene-expression marker or a cell-culture result is not the same as better health in a living animal.
- In what? Fast-ageing mouse models, naturally aged mice and people are very different evidence. Most of the results in this guide stop at mice.
- Who found it? Several of these peptides rest mainly on one research group’s work. Independent replication, like the 2025 Epitalon cell study, is what turns a claim into a finding.
Reasonably well established
- Each peptide here has published, peer-reviewed research on a specific ageing-related process.
- SS-31 has an FDA accelerated approval, and thymosin alpha-1 approvals abroad, for specific diseases.
Open questions
- Whether any of them slows ageing in humans; none has been shown to.
- How combinations behave; blends are rarely studied as blends.
- Long-term safety, which short studies cannot answer.
GHK-CuCopper tripeptide, tissue repairView product and COA
EpitalonTelomere researchView product and COA
SS-31Mitochondrial researchView product and COA
MOTS-cMetabolic signallingView product and COA
FOXO4-DRISenescence researchView product and COA
HumaninMitochondrial-derived peptideView product and COA
Also in the category: NAD+, N-acetyl Epitalon and Pinealon.
Sourcing anti-aging research peptides in Canada
This category spans very different molecules, from a three-residue peptide to a copper complex to a D-amino acid peptide, so the right checks vary. In every case:
- Match the mass to the exact compound, including modified forms such as N-acetyl versions. See the HPLC testing guide.
- Know the limits of standard testing. Mass spectrometry cannot tell D-amino acids from L-amino acids, which matters for FOXO4-DRI.
- Check the COA against your lot. How to read a certificate of analysis walks through it.
- Store cold, dry and dark. See our peptide storage guide.
Research use only. Anti-aging and cellular research peptides from Pure Peptides Canada are laboratory reagents. They are not approved drugs, supplements or anti-ageing products, they are not for human or veterinary use, and nothing in this article is dosing or medical guidance.
Frequently asked questions
What are anti-aging peptides?
“Anti-aging peptides” is an informal label for peptides studied against specific biological processes linked to ageing, such as telomere shortening, mitochondrial decline, cellular senescence and chronic inflammation. Examples include Epitalon, SS-31, MOTS-c, FOXO4-DRI and GHK-Cu.
Has any peptide been shown to slow human ageing?
No. Most of the research is in cells and animals. A few peptides have human data for specific diseases, such as SS-31 for Barth syndrome, but none has been shown to slow ageing in people.
What are the hallmarks of ageing?
They are a scientific framework, first published in 2013 and expanded in 2023 to twelve processes, that groups the biology of ageing into categories such as telomere attrition, mitochondrial dysfunction, cellular senescence and chronic inflammation.
Which anti-aging peptides have human data?
SS-31 (elamipretide) received FDA accelerated approval for Barth syndrome in 2025, thymosin alpha-1 is approved abroad for other conditions, and GHK-Cu has small topical cosmetic studies. The others rely mainly on cell and animal research.
Are any anti-aging peptides approved in Canada?
None is approved in Canada to treat or slow ageing. Pure Peptides Canada sells these compounds strictly as laboratory research reagents that are not for human or veterinary use.
Does Pure Peptides Canada ship these peptides across Canada?
Yes. Orders ship tracked and discreetly across Canada, usually arriving by Xpresspost in 3–7 days, or free in 4–12 days on orders over $299, with free shipping on orders over $299.
Anti-aging and cellular research peptides, tested batch by batch
GHK-Cu, Epitalon, SS-31, MOTS-c, FOXO4-DRI and more, each with an independent COA, tracked delivery across Canada and pricing in Canadian dollars.
References
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217.
- López-Otín C, et al. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243–278.
- Baar MP, et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell. 2017;169(1):132–147. DOI
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015. PubMed
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PubMed
For laboratory research use only. Not for human or veterinary use. This article summarizes published research for educational purposes and is not medical advice. Nothing here is intended to diagnose, treat, cure or prevent any disease.
